RecruitingNot ApplicableNCT07502833

Recto-intercostal Fascial Plane Block in Cholecystectomy

Recto-intercostal Fascial Plane Block Reduces Intraoperative Opioid and Volatile Anesthetic Use: a Randomized Trial in Cholecystectomy


Sponsor

Ankara Etlik City Hospital

Enrollment

64 participants

Start Date

Jan 3, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to evaluate whether an ultrasound-guided recto-intercostal fascial plane block performed before surgical incision in patients undergoing laparoscopic cholecystectomy reduces intraoperative opioid and volatile anesthetic consumption. Additionally, the study assesses its effects on postoperative pain and the incidence of nausea and vomiting.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Inclusion Criteria4

  • Adult patients aged 18-65 years
  • Scheduled for elective laparoscopic cholecystectomy
  • American Society of Anesthesiologists (ASA) physical status I-III
  • Ability to provide written informed consent

Exclusion Criteria7

  • Refusal to participate
  • Known allergy to local anesthetics
  • Coagulopathy or anticoagulant therapy
  • Infection at the injection site
  • Body weight less than 75 kg
  • Severe hepatic or renal dysfunction
  • Pregnancy or breastfeeding

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREProcedure: Recto-intercostal fascial plane block

A total of 30 mL of 0.25% bupivacaine is administered bilaterally under ultrasound guidance into the recto-intercostal fascial plane prior to surgical incision.


Locations(1)

Etlik City Hospital

Ankara, Türkiye, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07502833


Related Trials